LexaGene’s Largest Study Validates Accuracy of its Veterinary Test Panel

Technology Accurately Identifies Pathogens and Predicts Antimicrobial Resistance In less than 30 years, drug resistant bacteria are predicted to kill 3 times more people...

LexaGene Reports on Recent Veterinary Trade Shows

TW's Take: the veterinary market is an underserved, and underappreciated by investors, arena that can drive LexaGene's business over time as we await progress...

LexaGene’s MiQLab™ Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial Samples Compared to...

TW's Take: more positive news for the MiQLab, which is rapidly becoming the best in class product for veterinary lab use. BEVERLY, Mass. – September...

A September To Remember?

I read this week where someone said, "the short story is always sexier." There's certainly a lot of truth in that. Here in September...

LexaGene’s MiQLab(TM) System Featured at Three Key Veterinary Tradeshows

TW's Take: the veterinary market could grow into a cash cow for LexaGene over the next few years. We should start to see uptake...

Small Caps Rebound…August Recap

I'm calling it a month. Normally, I'd wait until August is officially over before recapping things, but, since we only have two days of...

LexaGene Demonstrates a Simple and Inexpensive Multiplex PCR Chemistry with Shorter Lead Times for...

TW's Take: LexaGene is building the leading point of care PCR diagnostic system. Eventually, the market will catch on to what they are doing.  BEVERLY,...

LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better Meet the Diagnostic...

TW's Take: we believe the market is missing the exciting opportunity in the vet space for LexaGene. Cash flow increasing monthly. Vet alone can...

Let’s Get Ready To Rumble (2nd Half Preview)

To steal a line from Charles Dickens, "It was the best of times. It was the worst of times. Then it was pretty darn...

LexaGene Advances Towards FDA Emergency Use Authorization

TW's Take: LexaGene's progress towards an EUA continues. The valuation is compelling and if an EUA is achieved, expect to see the stock trading...

Hoping for Fireworks

As the market seems to be slowly settling into summer, volatility is dropping and news flow is getting sparse. Amazing to think this is...

LexaGene’s MiQLab Offers Rapid Plague Detection for Bioterrorism Threats

TW's Take: the platform being developed by LexaGene has great functionality. The MiQLab is a disruptive force for diagnostics. BEVERLY, Mass., June 17, 2021 (GLOBE...

LexaGene Closes Sale to Alpine Veterinary Hospital

TW's Take: LexaGene is making great headway in the veterinary space. Very encouraged by their progress of late and believe there is a ton...

LexaGene detects a slow-growing bacterium at least 36-times faster than conventional methods with the...

TW's Take: the science behind MiQLab continues to demonstrate disruptive qualities. While the market awaits EUA approval, the stock has languished and represents a...

LexaGene Sells a MiQLab System to Denver Animal Emergency

TW's Take: watch the testimonial! This product is disruptive and going to be a big deal over the next year once it gets FDA...

LexaGene Partners with Ethos Discovery to Develop New Companion Animal Diagnostic Tests

TW's Take: the size of the veterinary market is greatly underappreciated by the market and makes LexaGene a great value play here. BEVERLY, Mass. USA...

LexaGene Takes Steps to List on the Nasdaq

TW's Take: a positive step that demonstrates the company's confidence in getting approval in the US for their diagnostic product. BEVERLY, Mass. USA – June...

LexaGene Expands Its Sales Team

TW's Take: we are encouraged to see the Company rapidly expanding their sales team. Vet diagnostics is easily a big enough industry to drive...

LEXAGENE HOSTS A SEMINAR TO PRESENT MIQLAB DATA FROM VETERINARY SAMPLES

TW's Take: excellent data as LexaGene now starts ramping up their sales team. The vet space has the potential for thousands of units and...

A Catalyst Filled Quarter Lies Around The Corner

My wife and I spent Good Friday in the car, driving up to Massachusetts to visit my number one newsletter fan; my mother. It...

LEXAGENE PROVIDES CORPORATE UPDATE

TW's Take: while disappointed in the stretched timeline for EUA approval, this is a very positive update. The vet market is sufficiently large to...

LEXAGENE RECEIVES $3.6M FROM THE EXERCISE OF WARRANTS

TW's Take: positive news for LexaGene putting more cash on the balance sheet as the company moves ever closer to their EUA filing. BEVERLY, Mass.,...

Heard On The Street

When I started in this business in the 1980s, "Heard on the Street" was a market moving column in the Wall Street Journal. R....

LexaGene Announces Change in Management and Appoints New Member to the Board of Directors

TW's Take: this is really a non-event for LexaGene, in terms of the business, however it is nice to get someone with a very...

LEXAGENE’S MIQLAB SUCCESSFULLY DETECTS MUTANT UK AND SOUTH AFRICAN COVID-19 SEQUENCES

TW's Take: while they will not incorporate these tests into their EUA application, LexaGene will be able to roll out additional tests broadly post...

The GameStop Impact…January In Review

What a crazy way to end a wild month, huh? As GameStop (GME) continued to rally in the face of shorts, Robin Hood required...

LEXAGENE INITIATES PROGRAM TO IDENTIFY UK AND SOUTH AFRICAN COVID SEQUENCES

TW's Take: the ability to rapidly diagnose different strains of Covid is a strength of LexaGene's open source system and a key differentiator versus...

LEXAGENE STARTS FDA EUA STUDY FOR POINT-OF-CARE COVID-19 TESTING

Tailwinds' Take: LexaGene is executing on their path to becoming a very disruptive force in the point-of-care diagnostics space. BEVERLY, Mass., Dec. 30, 2020 (GLOBE...

LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency Veterinary Care Hospitals

TW's Take: adoption is continuing. With an expected EUA application in early 2021, LexaGene is poised to disrupt the point-of-care diagnostics industry. BEVERLY, Mass. USA...

LexaGene Receives Purchase Order for MiQLab from Ethos Discovery

Tailwinds' Take: Positive news as products are shipping while we approach the pivotal EUA application coming soon. BEVERLY, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- LexaGene...

The Micro-Cap Rally Continues Full Force

November was truly a month to remember for the markets. The best month in over 40 years for the Russell 2000 saw that index...

A Micro Thanksgiving

Thanksgiving is usually a time to gather with friends and family to celebrate life. My favorite holiday of the year, it was always a...

LEXAGENE PLACES MIQLAB SYSTEM AT THE UNIVERSITY OF PENNSYLVANIA’S SCHOOL OF VETERINARY MEDICINE

Tailwinds' Take: We expect to see continued ramp-up of installations now that manufacturing has been ironed out and product is rolling out to the...

LEXAGENE RECEIVES PURCHASE ORDER FROM A MULTINATIONAL BIOTECHNOLOGY COMPANY

Tailwinds' Take: this is exciting news as the LexaGene PCR test is receiving customer approval prior to the official launch. The platform is very...

Time for Small Cap to Shine?

Small and micro-cap stocks have underperformed the market for quite a while now. Since I started Tailwinds in August of 2016, the Russell 2000...

LexaGene Provides a Corporate Update

Tailwinds' Take: LexaGene is approaching the finish line for bringing their technology to market. Delays in EUA approval are not uncommon and we remain...

The Final Push…

Like the debate, 2020 has been a sh**-show. Pandemics, political divisiveness, fires...it's not been a beach party to say the least. Yet, here we stand...

LexaGene’s CEO Provides Video Message on Company’s Progress and Announces Appointment of Dr. Shelley...

Tailwinds' Take: an excellent video update. LexaGene is on the cusp of FDA approval for Covid and launching product sales. The product could be...

West Bound and Down

After fortuitously sheltering in place on the east coast for seven weeks, we are heading back for CA this week. We seem to have,...

LexaGene’s Covid-19 Diagnostic Readies For The FDA

As we near the election, one thing that upon which both democrats and republicans seem to agree is that testing for Covid-19 has been...
DFC Advisory Services LLC (dba TW Research Group) is an investment adviser. We are also compensated for publishing information on certain companies. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.